Curigin co.
Latest round
- Series A
Last raised
- Apr 2021
Total raised
- $15M
Investors
- 8
About Curigin co.
, Ltd., Ltd. focuses on developing biopharmaceuticals.5 billion.??? specializes in the development and commercialization of innovative biopharmaceutical products aimed at addressing unmet medical needs. The company’s core offerings include advanced therapeutics for various diseases, leveraging proprietary technology platforms designed for enhanced efficacy and safety. These products are tailored to treat specific conditions and have been developed through rigorous clinical trials to ensure they meet regulatory standards. Their primary customer base consists of healthcare providers, including hospitals and clinics, as well as pharmaceutical distributors who facilitate access to end-users such as patients affected by chronic and acute medical conditions.'s products are marketed in key geographical regions, including North America, Europe, and parts of Asia, where there is a demand for therapeutic solutions.??? generates revenue primarily through direct sales of its biopharmaceutical products to healthcare institutions and through partnerships with distributors. The company operates a business-to-business (B2B) model, where products are sold to hospitals and clinics that then prescribe them to patients. Revenue is structured around transactional agreements that may include bulk purchase discounts for large orders or subscription models for ongoing supply agreements. One of the flagship products, known for its unique formulation, is offered at a competitive price point to ensure accessibility for healthcare providers., Ltd. The funds will ensure GMP-compliant manufacturing in preparation for its flagship products' clinical trials. Curigin plans to develop and launch several new products targeting unmet medical needs, with anticipated releases scheduled over the upcoming years. The company is also strategizing expansion into new markets across Europe and Asia by 2024, aiming to enhance its global footprint.
Who invested in Curigin co.
8 investors across 2 rounds
See all investors in Curigin co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Curigin co.
Who invested in Curigin co.?
Curigin co. has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Curigin co. raised?
Curigin co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Curigin co. last raise money?
Curigin co.'s most recent round on record is a Series A, in Apr 2021.
What does Curigin co. do?
Curigin co. is a biotechnology company.
Where is Curigin co. headquartered?
Curigin co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like Curigin co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Curigin co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Curigin co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.